| Target |
TNF-R2, TNFR-II, p80 TNF-alpha receptor, Etanercept, TNFBR, TBP-2, TBPII, Tumor necrosis factor receptor superfamily member 1B, CD120b, p75, TNFRSF1B, Tumor necrosis factor receptor 2, TNF-RII, TNFR2, Tumor necrosis factor receptor type II |
| Function |
InVivoMAb Anti-Human CD120b/TNFRSF1B/TNFR2 (SAA0309)[SAA0309] (ARO-A13374) is amouse monoclonalantibody detectingTNF-R2, TNFR-II, p80 TNF-alpha receptor, Etanercept, TNFBR, TBP-2, TBPII, Tumor necrosis factor receptor superfamily member 1B, CD120b, p75, TNFRSF1B, Tumor necrosis factor receptor 2, TNF-RII, TNFR2, Tumor necrosis factor receptor type IIinNeutralization. Suitable forHuman.HighlightsProtein A/G purified from cell culture supernatant.— Ensuring high specificity and minimal background.Validated for Neutralization— Optimized for consistent performance. |
